Bachem is a Swiss chemicals and biotechnology company, headquartered in Bubendorf. Bachem is specialized in the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients. In addition, biochemicals for research purposes and manufacturing processes are developed. The firm provides a number of products and services to the pharmaceutical and life science industries, including organic fine and performance chemicals, custom manufacturing of biopharmaceuticals, chemical synthesis capabilities and new chemical entities, and services for the bioscience sector. In 1971, Peter Grogg founded Bachem Feinchemikalien AG with two employees in Liestal near Basel with the focus on peptide synthesis. In 1977, Bachem moved with eight employees to nearby Bubendorf, and, in 1978, it manufactured, for the first time, peptides for use in medicine under cGMP guidelines. Between 1981 and 1991 Bachem tripled its production capacity and built an administration building, and in 1995, facilities were further expanded including the quality control department to a total of 168'000 sq. ft. (15'600 m2).